Bethesda Program

Published July 3, 2013

Bethesda Program –

Oncofetal Gene May Be Marker for Aggressive Liver Cancer

Filed under: bethesda alcohol and drug treatment program

The discovery that an oncofetal gene, SALL4, appears to be a marker for aggressive liver cancer has ignited hope that it can be used to screen patients and that it will offer a new target for drug development. "Hepatocellular carcinoma is the third …
Read more on Medscape

Anti-smoking Medication Shows Promise for Treating Alcohol Dependence

Filed under: bethesda alcohol and drug treatment program

Bethesda, Maryland–(ENEWSPF)–June 3, 2013. A smoking-cessation medication may … “Drinking and smoking often co-occur, and given their genetic and neurochemical similarities, it is perhaps unsurprising that a smoking cessation treatment might serve …
Read more on eNews Park Forest